Can Fite Biopharma
CANF
$1.98
Share price
3.13%
Change (1 day)
12.50%
Change (1 year)
Categories
Can Fite Biopharma (CANF) - Cash on Hand
Cash on Hand as of September 2023 : $7.94 M
According to Can Fite Biopharma
's latest financial reports the company has $7.94 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Can Fite Biopharma - Cash on Hand chart (from 2011 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $7.98 M | -58.27% |
| 2021-12-31 | $19.13 M | 129.4% |
| 2020-12-31 | $8.34 M | 202.17% |
| 2019-12-31 | $2.76 M | -28.99% |
| 2018-12-31 | $3.88 M | 10.93% |
| 2017-12-31 | $3.5 M | -56.79% |
| 2016-12-31 | $8.11 M | -52.04% |
| 2015-12-31 | $16.91 M | 82.49% |
| 2014-12-31 | $9.26 M | 55.43% |
| 2013-12-31 | $5.96 M | 420.76% |
| 2012-12-31 | $1.14 M | -70.19% |
| 2011-12-31 | $3.84 M |